Your Location:
Home >
Browse articles >
Material Basis and Mechanism of Shenling Baizhusan for Treatment of Type 2 Diabetes Based on Integrated Pharmacological Platform
Material Basis and Mechanism of Shenling Baizhusan for Treatment of Type 2 Diabetes Based on Integrated Pharmacological Platform
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 21, Pages: 157-162(2018)
DOI: 10.13422/j.cnki.syfjx.20182014
Scan QR Code
Full Text(HTML)
Publication Info
Metrics
33
Views
446
Downloads
9
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Improvement of Emotional State of Rats with Diarrhea-predominant Irritable Bowel Syndrome by Shenling Baizhusan with Codonopsis Radix as Monarch Drug
Based on 16S rDNA Technology and TLRs/MyD88/NF-κB Signaling Pathway, Molecular Mechanism of Shenling Baizhusan Resistance to Diarrhea Irritable Bowel Syndrome Rats Was Investigated
Effect of Jianpi Qinghua Granules on Blood Glucose Fluctuations and Skeletal Muscle Mass and Function in Newly Diagnosed Overweight/Obese Type 2 Diabetes Patients with Qi-Yin Deficiency Syndrome
Effect of Gynostemma pentaphyllum Alcohol Extract on Glucose and Lipid Metabolism Disorders in db/db Mice Based on Transcriptomics and Gut Microbiota
Mechanism of Action of Coptidis Rhizoma and Ophiopogonis Radix in Delaying Diabetic Nephropathy Based on EGFR/PI3K/Akt Signaling Pathway
Related Author
HAN Guanghui
WU Wenyu
LIU Jiabao
ZHANG Xueping
YANG Yang
LIANG Kun
WEI Wei
LYU Tengfei
Related Institution
Wangjing Hospital, China Academy of Chinese Medical Sciences
Henan University of Chinese Medicine School of Management
The Second Clinical Medical College of Henan University of Traditional Chinese Medicine
Shuguang Hospital, Shanghai University of Traditional Chinese Medicine(TCM)
Hubei Provincial Hospital of TCM


